Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach

PLoS Medicine

Volumn 14, Issue 1, 2017, Pages

  Mendelson, Michael M ^a,b,c,d   Marioni, Riccardo E ^e,f   Joehanes, Roby ^a,d,g   Liu, Chunyu ^a,d,h   Hedman, Åsa K ⁱ   Aslibekyan, Stella ^j   Demerath, Ellen W ^k   Guan, Weihua ^k   Zhi, Degui ^j   Yao, Chen ^a,d   Huan, Tianxiao ^a,d   Willinger, Christine ^a,d   Chen, Brian ^d   Courchesne, Paul ^a,d   Multhaup, Michael ^l   Irvin, Marguerite R ^j   Cohain, Ariella ^m   Schadt, Eric E ^m   Grove, Megan L ⁿ   Bressler, Jan ⁿ   North, Kari ^o   Sundström, Johan ⁱ   Gustafsson, Stefan ⁱ   Shah, Sonia ^f   McRae, Allan F ^f   Harris, Sarah E ^e   Gibson, Jude ^e   Redmond, Paul ^e   Corley, Janie ^e   Murphy, Lee ^e   Starr, John M ^e   Kleinbrink, Erica ^p   Lipovich, Leonard ^p   Visscher, Peter M ^e,f   Wray, Naomi R ^f   Krauss, Ronald M ^q   Fallin, Daniele ^l   Feinberg, Andrew ^l   Absher, Devin M ^r   Fornage, Myriam ^n,v   Pankow, James S ^k   Lind, Lars ⁱ   Fox, Caroline ^a,d   Ingelsson, Erik ^i,t   Arnett, Donna K ^w   Boerwinkle, Eric ^n,s   Liang, Liming ^u   Levy, Daniel ^a,d   Deary, Ian J ^e   more..

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g HARVARD MEDICAL SCHOOL   (United States)

^h BOSTON UNIVERSITY   (United States)

ⁱ UPPSALA UNIVERSITY   (Sweden)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^o IL   (United States)

^p WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^r HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^s BAYLOR COLLEGE OF MEDICINE   (United States)

^t STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^v UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^w UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; BLOOD CELL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DOWNSTREAM PROCESSING; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; HUMAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS (TOPIC); MICROARRAY ANALYSIS; NORMAL HUMAN; OBESITY; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LEUKOCYTE; LIPID METABOLISM; METABOLISM; PROCEDURES;

AGED; BODY MASS INDEX; CORONARY ARTERY DISEASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEUKOCYTES; LIPID METABOLISM; MALE; MENDELIAN RANDOMIZATION ANALYSIS; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 85010976480     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002215     Document Type: Article

References (92)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM, Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–14. doi: 10.1001/jama.2014.73224570244
2. Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG, The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103(10):1895–901. doi: 10.2105/AJPH.2013.30137923948004
3. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G, Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970–83. doi: 10.1016/S0140-6736(13)61836-X24269108
4. Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45(5):501–12. doi: 10.1038/ng.260623563607
5. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937–48. doi: 10.1038/ng.68620935630
6. van Vliet-Ostaptchouk JV, Snieder H, Lagou V, Gene-lifestyle interactions in obesity. Curr Nutr Rep. 2012;1:184–96. doi: 10.1007/s13668-012-0022-224392269
7. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. doi: 10.1038/nature1417725673413
8. Relton CL, Davey Smith G, Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med. 2010;7(10):e1000356. doi: 10.1371/journal.pmed.100035621048988
9. van Dijk SJ, Molloy PL, Varinli H, Morrison JL, Muhlhausler BS, Epigenetics and human obesity. Int J Obes (Lond). 2014;39(1):85–97. doi: 10.1038/ijo.2014.3424566855
10. Bray MS, Loos RJ, McCaffery JM, Ling C, Franks PW, Weinstock GM, et al. NIH working group report-using genomic information to guide weight management: From universal to precision treatment. Obesity (Silver Spring). 2016;24(1):14–22. doi: 10.1002/oby.2138126692578
11. Relton CL, Davey Smith G, Mendelian randomization: applications and limitations in epigenetic studies. Epigenomics. 2015;7(8):1239–43. doi: 10.2217/epi.15.8826639554
12. Relton CL, Davey Smith G, Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41(1):161–76. doi: 10.1093/ije/dyr23322422451
13. Burgess S, Small DS, Thompson SG, A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2015Aug17. doi: 10.1177/096228021559757926282889
14. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP, An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979;110(3):281–90. 474565
15. Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC, The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol. 2004;86(1):130–47. doi: 10.1037/0022-3514.86.1.13014717632
16. Deary IJ, Gow AJ, Taylor MD, Corley J, Brett C, Wilson V, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007;7:28. doi: 10.1186/1471-2318-7-2818053258
17. Deary IJ, Gow AJ, Pattie A, Starr JM, Cohort profile: the Lothian Birth Cohorts of 1921 and 1936. Int J Epidemiol. 2012;41(6):1576–84. doi: 10.1093/ije/dyr19722253310
18. Dawber TR, Meadors GF, Moore FE, JrEpidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951;41(3):279–81. 14819398
19. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011;98(4):288–95. doi: 10.1016/j.ygeno.2011.07.00721839163
20. Zhang X, Johnson AD, Hendricks AE, Hwang SJ, Tanriverdi K, Ganesh SK, et al. Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet. 2014;23(3):782–95. doi: 10.1093/hmg/ddt46124057673
21. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD, The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–3. doi: 10.1093/bioinformatics/bts03422257669
22. Zaykin DV, Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol. 2011;24(8):1836–41. doi: 10.1111/j.1420-9101.2011.02297.x21605215
23. Mi H, Muruganujan A, Casagrande JT, Thomas PD, Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013;8(8):1551–66. doi: 10.1038/nprot.2013.09223868073
24. Breeze CE, Paul DS, van Dongen J, Butcher LM, Ambrose JC, Barrett JE, et al. eFORGE: a tool for identifying cell type-specific signal in epigenomic data. Cell Rep. 2016;17(8):2137–50. doi: 10.1016/j.celrep.2016.10.05927851974
25. Roadmap Epigenomics ConsortiumKundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–30. doi: 10.1038/nature1424825693563
26. Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, et al. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol. 2012;30(3):224–6. doi: 10.1038/nbt.215322398613
27. ENCODE Project ConsortiumAn integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. doi: 10.1038/nature1124722955616
28. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aissi D, Wahl S, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383(9933):1990–8. doi: 10.1016/S0140-6736(13)62674-424630777
29. Aslibekyan S, Demerath EW, Mendelson M, Zhi D, Guan W, Liang L, et al. Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference. Obesity (Silver Spring). 2015;23(7):1493–501. doi: 10.1002/oby.2111126110892
30. Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou YH, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015;24(15):4464–79. doi: 10.1093/hmg/ddv16125935004
31. Ding J, Reynolds LM, Zeller T, Muller C, Lohman K, Nicklas BJ, et al. Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease. Diabetes. 2015;64(10):3464–74. doi: 10.2337/db14-131426153245
32. Huang RC, Garratt ES, Pan H, Wu Y, Davis EA, Barton SJ, et al. Genome-wide methylation analysis identifies differentially methylated CpG loci associated with severe obesity in childhood. Epigenetics. 2015;10(11):995–1005. doi: 10.1080/15592294.2015.108041126646899
33. Ronn T, Volkov P, Gillberg L, Kokosar M, Perfilyev A, Jacobsen AL, et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum Mol Genet. 2015;24(13):3792–813. doi: 10.1093/hmg/ddv12425861810
34. Al Muftah WA, Al-Shafai M, Zaghlool SB, Visconti A, Tsai PC, Kumar P, et al. Epigenetic associations of type 2 diabetes and BMI in an Arab population. Clin Epigenetics. 2016;8:13. doi: 10.1186/s13148-016-0177-626823690
35. Mansego ML, Milagro FI, Zulet MA, Moreno-Aliaga MJ, Martinez JA, Differential DNA methylation in relation to age and health risks of obesity. Int J Mol Sci. 2015;16(8):16816–32. doi: 10.3390/ijms16081681626213922
36. Ali O, Cerjak D, Kent JW, JrJames R, Blangero J, Carless MA, et al. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity. Epigenetics. 2016Aug26. doi: 10.1080/15592294.2016.121628427564309
37. Buchmann J, Meyer C, Neschen S, Augustin R, Schmolz K, Kluge R, et al. Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. Endocrinology. 2007;148(4):1561–73. doi: 10.1210/en.2006-124417194745
38. Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(7351):337–42. doi: 10.1038/nature1016321677750
39. Nyman LR, Cox KB, Hoppel CL, Kerner J, Barnoski BL, Hamm DA, et al. Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol Genet Metab. 2005;86(1–2):179–87. doi: 10.1016/j.ymgme.2005.07.02116169268
40. Wechsler A, Brafman A, Shafir M, Heverin M, Gottlieb H, Damari G, et al. Generation of viable cholesterol-free mice. Science. 2003;302(5653):2087. doi: 10.1126/science.109077614684813
41. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL, Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 1996;98(7):1575–84. doi: 10.1172/JCI1189518833906
42. Kim S, Huang LW, Snow KJ, Ablamunits V, Hasham MG, Young TH, et al. A mouse model of conditional lipodystrophy. Proc Natl Acad Sci U S A. 2007;104(42):16627–32. doi: 10.1073/pnas.070779710417921248
43. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 1998;12(20):3182–94. 9784493
44. Takahashi A, Shimano H, Nakagawa Y, Yamamoto T, Motomura K, Matsuzaka T, et al. Transgenic mice overexpressing SREBP-1a under the control of the PEPCK promoter exhibit insulin resistance, but not diabetes. Biochim Biophys Acta. 2005;1740(3):427–33. doi: 10.1016/j.bbadis.2004.11.00615949711
45. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ, et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 2011;7(8):e1002197. doi: 10.1371/journal.pgen.100219721829388
46. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008;6(5):e107. doi: 10.1371/journal.pbio.006010718462017
47. Greenawalt DM, Dobrin R, Chudin E, Hatoum IJ, Suver C, Beaulaurier J, et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res. 2011;21(7):1008–16. doi: 10.1101/gr.112821.11021602305
48. Grundberg E, Meduri E, Sandling JK, Hedman AK, Keildson S, Buil A, et al. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am J Hum Genet. 2013;93(5):876–90. doi: 10.1016/j.ajhg.2013.10.00424183450
49. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet. 2010;42(11):949–60. doi: 10.1038/ng.68520935629
50. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3):e1002607. doi: 10.1371/journal.pgen.100260722479202
51. Horikoshi M, Yaghootkar H, Mook-Kanamori DO, Sovio U, Taal HR, Hennig BJ, et al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet. 2013;45(1):76–82. doi: 10.1038/ng.247723202124
52. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90. doi: 10.1038/ng.238322885922
53. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44(6):659–69. doi: 10.1038/ng.227422581228
54. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59(12):3229–39. doi: 10.2337/db10-050220858683
55. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–16. doi: 10.1038/ng.52020081858
56. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707–13. doi: 10.1038/nature0927020686565
57. CARDIoGRAMplusC4D ConsortiumDeloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33. doi: 10.1038/ng.248023202125
58. Barber MJ, Mangravite LM, Hyde CL, Chasman DI, Smith JD, McCarty CA, et al. Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS ONE. 2010;5(3):e9763. doi: 10.1371/journal.pone.000976320339536
59. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, Attar-Cohen H, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science. 2009;325(5945):1246–50. doi: 10.1126/science.117414819644074
60. Consortium GTEx, Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648–60. doi: 10.1126/science.126211025954001
61. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–83. doi: 10.1038/ng.279724097068
62. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96. doi: 10.1016/S0140-6736(09)60318-419299006
63. Mongraw-Chaffin ML, Peters SA, Huxley RR, Woodward M, The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1.2 million participants. Lancet Diabetes Endocrinol. 2015;3(6):437–49. doi: 10.1016/S2213-8587(15)00086-825960160
64. Strable MS, Ntambi JM, Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol. 2010;45(3):199–214. doi: 10.3109/1040923100366750020218765
65. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376–88. doi: 10.1016/j.cmet.2011.03.00921459323
66. Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345–52. doi: 10.1038/ng.279524097064
67. Feldkircher KM, Mistry AM, Romsos DR, Adrenalectomy reverses pre-existing obesity in adult genetically obese (ob/ob) mice. Int J Obes Relat Metab Disord. 1996;20(3):232–5. 8653144
68. Solomon J, Mayer J, The effect of adrenalectomy on the development of the obese-hyperglycemic syndrome in ob-ob mice. Endocrinology. 1973;93(2):510–2. doi: 10.1210/endo-93-2-5104718888
69. Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–58. doi: 10.1016/j.cell.2015.01.01225662011
70. Frisdal E, Le Lay S, Hooton H, Poupel L, Olivier M, Alili R, et al. Adipocyte Atp-binding cassette G1 promotes triglyceride storage, fat mass growth and human obesity. Diabetes. 2015;64(3):840–55. doi: 10.2337/db14-024525249572
71. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study. Diabetes. 2014;63(2):801–7. doi: 10.2337/db13-110024170695
72. Irvin MR, Zhi D, Joehanes R, Mendelson M, Aslibekyan S, Claas SA, et al. Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study. Circulation. 2014;130(7):565–72. doi: 10.1161/CIRCULATIONAHA.114.00915824920721
73. Pfeiffer L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet. 2015;8(2):334–42. doi: 10.1161/CIRCGENETICS.114.00080425583993
74. Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3(7):526–34. doi: 10.1016/S2213-8587(15)00127-826095709
75. Sayols-Baixeras S, Subirana I, Lluis-Ganella C, Civeira F, Roquer J, Do AN, et al. Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study. Hum Mol Genet. 2016Sep15. doi: 10.1093/hmg/ddw28527634649
76. Dekkers KF, van Iterson M, Slieker RC, Moed MH, Bonder MJ, van Galen M, et al. Blood lipids influence DNA methylation in circulating cells. Genome Biol. 2016;17(1):138. doi: 10.1186/s13059-016-1000-627350042
77. Folmes CD, Lopaschuk GD, Role of malonyl-CoA in heart disease and the hypothalamic control of obesity. Cardiovasc Res. 2007;73(2):278–87. doi: 10.1016/j.cardiores.2006.10.00817126822
78. Schreurs M, Kuipers F, van der Leij FR, Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes Rev. 2010;11(5):380–8. doi: 10.1111/j.1467-789X.2009.00642.x19694967
79. Hersoug LG, Moller P, Loft S, Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obes Rev. 2016;17(4):297–312. doi: 10.1111/obr.1237026712364
80. Bansal K, Balaji KN, Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. J Biol Chem. 2011;286(7):5823–35. doi: 10.1074/jbc.M110.19239321156799
81. Yuan H, Zelkha S, Burkatovskaya M, Gupte R, Leeman SE, Amar S, Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci U S A. 2013;110(52):E5059–68. doi: 10.1073/pnas.132086211024324141
82. Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Mori K, et al. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology. 2015;62(5):1433–43. doi: 10.1002/hep.2800226199205
83. Maekawa T, Kamada Y, Ebisutani Y, Ueda M, Hata T, Kawamoto K, et al. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. World J Gastroenterol. 2016;22(17):4403–10. doi: 10.3748/wjg.v22.i17.440327158210
84. Campion J, Milagro FI, Martinez JA, Individuality and epigenetics in obesity. Obes Rev. 2009;10(4):383–92. doi: 10.1111/j.1467-789X.2009.00595.x19413700
85. Richmond RC, Sharp GC, Ward ME, Fraser A, Lyttleton O, McArdle WL, et al. DNA methylation and body mass index: investigating identified methylation sites at HIF3A in a causal framework. Diabetes. 2016;65(5):1231–44. doi: 10.2337/db15-099626861784
86. Petersen AK, Zeilinger S, Kastenmuller G, Romisch-Margl W, Brugger M, Peters A, et al. Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Hum Mol Genet. 2014;23(2):534–45. doi: 10.1093/hmg/ddt43024014485
87. Bikman BT, Summers SA, Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest. 2011;121(11):4222–30. doi: 10.1172/JCI5714422045572
88. Borodzicz S, Czarzasta K, Kuch M, Cudnoch-Jedrzejewska A, Sphingolipids in cardiovascular diseases and metabolic disorders. Lipids Health Dis. 2015;14:55. doi: 10.1186/s12944-015-0053-y26076974
89. Bellini L, Campana M, Mahfouz R, Carlier A, Veret J, Magnan C, et al. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes. Expert Opin Ther Targets. 2015;19(8):1037–50. doi: 10.1517/14728222.2015.102835925814122
90. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gomez-Marin C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507(7492):371–5. doi: 10.1038/nature1313824646999
91. Shah S, Bonder MJ, Marioni RE, Zhu Z, McRae AF, Zhernakova A, et al. Improving phenotypic prediction by combining genetic and epigenetic associations. Am J Hum Genet. 2015;97(1):75–85. doi: 10.1016/j.ajhg.2015.05.01426119815
92. Ma B, Wilker EH, Willis-Owen SA, Byun HM, Wong KC, Motta V, et al. Predicting DNA methylation level across human tissues. Nucleic Acids Res. 2014;42(6):3515–28. doi: 10.1093/nar/gkt138024445802